Pediatrix Medical Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pediatrix Medical Group generated cash of $137,325,000, which is less than the previous year. Cash used in financing activities reached the amount of -$25,715,000 last year. Net change in cash is therefore $63,434,000.
Cash Flow
| 2014 | 422.64M | -503.60M | 97.75M |
|---|---|---|---|
| 2015 | 368.70M | -848M | 482.94M |
| 2016 | 443.77M | -821.21M | 381.56M |
| 2017 | 511.37M | -576.61M | 89.73M |
| 2018 | 289.92M | -142.76M | -170.61M |
| 2019 | 346.63M | 102.45M | -393.07M |
| 2020 | 204.62M | 815.51M | -4.15M |
| 2021 | 76.73M | -53.07M | -760.11M |
| 2022 | 166.94M | -56.95M | -487.55M |
| 2023 | 137.32M | -48.17M | -25.71M |
MD Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.82M | 387.39M | 1.12B | 107.87M | 56.74M | 80.2M | 55.69M | 51.57M | 47.92M | 31.13M |
Operating activities | ||||||||||
Net income | -60.40M | 62.56M | 108.01M | -9.58M | -1.15B | 268.62M | 320.37M | 324.59M | 335.69M | 317.20M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 36.17M | 35.63M | 32.14M | 28.44M | 78.86M | 111.28M | 102.87M | 89.26M | 64.22M | 45.99M |
Stock-based compensation expense | 12.32M | 16.12M | 18.96M | 39.04M | 35.35M | 0 | 29.57M | 34M | 32.12M | 31.71M |
| Deferred income tax benefit | 12.32M | 16.12M | 18.96M | 39.04M | 35.35M | 0 | 29.57M | 34M | 32.12M | 31.71M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 26.27M | -5.54M | -72.73M | 37.93M | 7.85M | -36.59M | 7.80M | -34M | -55.39M | -57.01M |
Inventories | 0 | 0 | 0 | -54.88M | -34.11M | -66.72M | 70.25M | -3.01M | -7.36M | 10.64M |
Accounts payable | 0 | 420K | 21.32M | 47.90M | 104.16M | 15.39M | 24.55M | 11.61M | -7.87M | 66.03M |
Cash generated by operating activities | 137.32M | 166.94M | 76.73M | 204.62M | 346.63M | 289.92M | 511.37M | 443.77M | 368.70M | 422.64M |
Investing activities | ||||||||||
Purchases Of Investments | -31.89M | -17.34M | -35.05M | -61.84M | -35.10M | -15.88M | -27.72M | -60.97M | -33.98M | -26.88M |
Investments In Property Plant And Equipment | -33.32M | -29.70M | -32.24M | -28.78M | -31.88M | -48.86M | -49.30M | -39.26M | -27.07M | -18.06M |
Acquisitions Net | -6.66M | -28.16M | -5.20M | -1.14M | 137.75M | -91.72M | -531.69M | -762.30M | -818.90M | -479.39M |
Cash generated by investing activities | -48.17M | -56.95M | -53.07M | 815.51M | 102.45M | -142.76M | -576.61M | -821.21M | -848M | -503.60M |
Financing activities | ||||||||||
Common Stock Issued | 4.91M | 5.39M | 6.85M | 7.00M | 11.25M | 16.25M | 23.27M | 22.02M | 20.12M | 42.87M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -919K | -88.51M | -4.71M | -8.49M | -145.28M | -302.16M | -70.19M | -61.82M | -235.05M | -488.42M |
Repayments of term debt | -19.11M | -405.17M | -762.65M | -528.66M | -248.69M | -2.09B | 145.34M | -1.51B | 713.32M | -1.21B |
Cash used in financing activities | -25.71M | -487.55M | -760.11M | -4.15M | -393.07M | -170.61M | 89.73M | 381.56M | 482.94M | 97.75M |
Net Change In Cash | 63.43M | -377.56M | -736.45M | 1.01B | 56.02M | -23.45M | 24.50M | 4.12M | 3.64M | 16.79M |
Cash at end of period | 73.25M | 9.82M | 387.39M | 1.12B | 112.76M | 56.74M | 80.2M | 55.69M | 51.57M | 47.92M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |